Kilian Eyerich, Natalie Garzorz-StarkFirst published: 14 September 2023 AbstractPsoriasis and eczema are noncommunicable inflammatory skin diseases (ncISDs) that may present with overlapping clinical and histopathological features, making their differential diagnosis a pertinent challenge for clinicians. Treatments with highly effective mAbs for psoriasis and eczema are increasingly replacing broadly acting immunosuppressant drugs such as methotrexate and

July 9, 2023: Histopathological differentiation of early mycosis fungoides (MF) from benign chronic inflammatory dermatoses remains difficult…

Felix Fischer, Anais Doll, Deniz Uereyener, Sophie Roenneberg, Christina Hillig, Lucca Weber, Verena Hackert, Martin Meinel, Ali Farnoud, Peter Seiringer, Jenny Thomas, Philipp Anand, Larissa Graner, Franziska Schlenker, Roland Zengerle, Pontus Jonsson, Manja Jargosch, Fabian J Theis, Carsten B Schmidt-Weber, Tilo Biedermann, Michael Howell, Kristian Reich, Kilian Eyerich, Michael Menden, Natalie Garzorz-Stark, Felix Lauffer, Stefanie

February 22, 2023: High amounts of clinically unclear cases point out the need for a new diagnostic tool to differentiate psoriasis from eczema…

October 14, 2022: Centrifugal microfluidics enables fully automated molecular diagnostics at the point-ofneed. However, the integration of solid-phase nucleic acid extraction remains a challenge.

Philipp Bentz, Kilian Eyerich, Elke WeisshaarFirst published: 26 September 2022 Dear Editors, hand eczema is a complex and multifactorial skin disease, for which treatment remains challenging . The most im-portant differential diagnosis is psoriasis. An exact diag-nosis is often not possible, due to a similar clinical picture. Moreover, dermatopathohistological analysis often cannot distinguish between the

May 22, 2022: Highly specific and efficient drugs have been developed during the last two decades to treat non-communicable chronic inflammatory skin diseases (ncISD).

May 8, 2022: Contact dermatitis is an inflammation of the epidermis and dermis at the site of exposure triggered by external agents.

Daniel M. Kainz, Bastian J. Breiner, Susanna M. Früh, Tobias Hutzenlaub, Roland Zengerle & Nils PaustFirst published: 06 September 2021 AbstractDespite the widespread application of point-of-care lateral flow tests, the viscosity dependence of these assay results remains a significant challenge. Here, we employ centrifugal microfluidic flow control through the nitrocellulose membrane of the strip to

Markus Rombach , Sebastian Hin , Mara Specht, Benita Johannsen , Jan Lüddecke a Nils Paust , Roland Zengerle , Louis Roux , Thomas Sutcliffe , Johannes R. Peham , Christopher Herz , Marcus Panning , Oliver Donoso Mantke and Konstantinos MitsakakisFirst published: 02 September 2020 AbstractWe present the RespiDisk enabling the fully automated and